A Case Series of Third-Trimester Raltegravir Initiation: Impact on Maternal HIV-1 Viral Load and Obstetrical Outcomes
OBJECTIVE: To describe the impact of initiating raltegravir (RAL)-containing combination antiretroviral therapy (cART) regimens on HIV viral load (VL) in pregnant women who have high or suboptimal VL suppression late in pregnancy.
Main Authors: | I Boucoiran, K Tulloch, N Pick, F Kakkar, J van Schalkwyk, D Money, M Boucher |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2015/731043 |
Similar Items
-
Rapid Reduction in HIV Viral Load in Late Pregnancy with Raltegravir
by: Agnes Cha PharmD, et al.
Published: (2013-09-01) -
Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
by: Jos Lommerse, et al.
Published: (2019-09-01) -
The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein
by: Greenberg Cheryl R, et al.
Published: (2004-09-01) -
Maternal and Perinatal Outcome in Pregnancies with Oligohydramnios in Third Trimester
by: Manisha Sharma, et al.
Published: (2016-07-01) -
Maternal hypothermia from environmental exposure in the third trimester
by: Margot Rosenthal, et al.
Published: (2020-01-01)